AMN Healthcare's Q3 Beat Was Real, but the Source Won't Last
As seen on the 24/7 Wall St. homepage on November 5, 2026.
Labor disruption work delivered $59 million of revenue, up from $12 million a year ago, and that windfall plus a reserve release is why earnings came in five times consensus. The catch is in the guidance: management sees just $5 million of labor disruption revenue in Q4, with adjusted EBITDA margin compressing to 5.8% to 6.3%.
Continue ReadingShow less
AMN Healthcare reported Q3 2026 revenue of $717.3 million, up 13.1% year over year and about 10% ahead of the $649.5 million consensus estimate. Adjusted EPS of $1.16 beat the $0.23 estimate by more than 400%, a margin of outperformance that immediately raises the question of what drove it and whether it can repeat.
Labor disruption drove the quarter. Hospitals hit by strikes and work stoppages needed emergency staffing, and AMN delivered $59 million of revenue from that activity in the quarter, up from $12 million a year earlier. A reserve release tied to prior strike-support staffing events added further lift to earnings, which is why the bottom line looked so much more dramatic than the top line.
Beyond the one-time tailwinds, the underlying nursing and allied business showed genuine momentum. Travel nurse staffing revenue rose 19% year over year, and the average number of travelers on assignment climbed to 9,486 from 8,203 in the year-ago quarter. The Nurse and Allied Solutions segment as a whole posted revenue of $460 million, up 27% year over year, with gross margin expanding to 30.9% from 24.1% a year earlier.
Sponsored
The forward picture is where investors need to pay close attention. Management guided Q4 2026 consolidated revenue to $655 million to $670 million, a decline of 10 to 12% from the prior year. Labor disruption revenue, which was $124 million in Q4 2025, is expected to contribute just $5 million in the coming quarter, and adjusted EBITDA margin is projected to compress sharply, to a range of 5.8% to 6.3% compared with 13.0% in Q3. Operating margin is guided to as low as negative 0.1%.
The EPS history adds useful context. AMN has consistently beaten consensus estimates in recent quarters, but the magnitude of those beats has swung dramatically based on nonrecurring items, with Q1 2026 showing a reported $2.10 against an $1.62 estimate and Q4 2025 falling short at $0.22 versus a $0.27 estimate. The Q3 2026 result fits that pattern of lumpy, event-driven outperformance rather than a straight-line improvement in the core business.
Sources
Mentioned: AMN